glutamine has been researched along with Cognitive Decline in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (52.63) | 24.3611 |
| 2020's | 9 (47.37) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Lai, KP; Liu, J; Mai, T; Nong, Y; Wang, Y; Zhang, X; Zhang, Z | 1 |
| Česnaitienė, VJ; Drozdova-Statkevičienė, M; Dudonienė, V; Gleiznienė, R; Himmelreich, U; Katkutė, G; Kušleikienė, S; Levin, O; Masiulis, N; Pääsuke, M; Sheoran, S; Valatkevičienė, K; Vints, WAJ; Ziv, G | 1 |
| Baek, JH; Kang, JS; Kim, HJ; Lee, DK; Song, M | 1 |
| Grochecki, P; Kochalska, K; Kotlinska, JH; Marszalek-Grabska, M; Matosiuk, D; Michalak, A; Ner-Kluza, J; Pankowska, A; Suder, P | 1 |
| Alt, J; Calabresi, PA; Hollinger, KR; Kirby, LA; Prchalova, E; Rais, R; Slusher, BS; Smith, MD | 1 |
| Abe, K; Deguchi, K; Higashi, Y; Hishikawa, N; Inufusa, H; Kawano, S; Kutoku, Y; Manabe, Y; Matsumoto, N; Morihara, R; Morimoto, N; Nakano, Y; Nomura, E; Ohta, Y; Sasaki, R; Sunada, Y; Tadokoro, K; Takahashi, Y; Takao, Y; Takemoto, M; Taomoto, K; Ueno, S; von Greiffenclau, MM; Wakutani, Y; Yamashita, T; Yoshikawa, T; You, F | 1 |
| Howell, JC; Hu, WT; Jones, DP; Miller, GW; Niedzwiecki, MM; Walker, DI; Watts, KD | 1 |
| Adams, CD | 1 |
| Baek, JH; Jung, S; Kang, JS; Kim, HJ; Son, H | 1 |
| Gurler, D; Kraguljac, NV; Lahti, AC; Martin, C; Tennant, B; Ver Hoef, L; White, DM | 1 |
| Chen, X; Ding, Y; Gao, M; He, N; Lin, H; Shen, W; Xu, X; Zhu, B | 1 |
| Guo, Y; Jiang, H; Li, W; Liu, H; Nie, Z; Pu, X; Sun, Y; Wang, C; Xiong, X; Zhang, K; Zhang, X; Zhao, X | 1 |
| Cassol, G; de Carvalho Gonçalves, M; de Zorzi, VN; Della-Pace, ID; Farinha, JB; Fighera, MR; Furian, AF; Godinho, DB; Oliveira, MS; Royes, LFF | 1 |
| Chen, SD; Deng, YL; Huang, FJ; Jia, W; Liu, JJ; Ma, JF; Ren, RJ; Tang, HD; Wang, G; Wang, Y; Xu, W; Xu, XH; Zhang, YN; Zhao, AH; Zhou, Y | 1 |
| Choe, BY; Jahng, GH; Kim, HG; Lee, DW; Lee, KM; Oh, J; Paik, JW; Park, S; Rhee, HY; Ryu, CW; Shin, W | 1 |
| Confort-Gouny, S; Cozzone, PJ; Girard, N; Koob, M; Le Fur, Y; Ratiney, H; Viola, A; Viout, P | 1 |
| Huang, D; Liu, D; Ni, H; Qian, T; Shrestha, S; Yin, J | 1 |
| Campagna, G; Grilli, A; La Fratta, I; Pesce, M; Rizzuto, A; Tatangelo, R | 1 |
| Barcikowska, M; Ćwikła, JB; Gabryelewicz, T; Walecki, J | 1 |
2 review(s) available for glutamine and Cognitive Decline
| Article | Year |
|---|---|
Potential therapeutic implications of ergogenic compounds on pathophysiology induced by traumatic brain injury: A narrative review.
Topics: Animals; Arginine; Brain Injuries, Traumatic; Caffeine; Carnitine; Central Nervous System Stimulants; Cognitive Dysfunction; Creatine; Energy Metabolism; Epilepsy, Post-Traumatic; Glutamine; Humans; Mitochondria; Neuromuscular Diseases; Taurine | 2019 |
The progression of coeliac disease: its neurological and psychiatric implications.
Topics: Adult; Celiac Disease; Cognitive Dysfunction; Diet, Gluten-Free; Disease Progression; Edible Grain; Environment; Female; Genetic Predisposition to Disease; Glutamine; Humans; Immune System Diseases; Immunity; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Plant Proteins; Proline | 2017 |
1 trial(s) available for glutamine and Cognitive Decline
| Article | Year |
|---|---|
Clinical Benefits of Antioxidative Supplement Twendee X for Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Prospective Interventional Study.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; Cognition; Cognitive Dysfunction; Cystine; Dietary Supplements; Double-Blind Method; Female; Glutamine; Humans; Male; Mental Status and Dementia Tests; Prospective Studies; Treatment Outcome | 2019 |
16 other study(ies) available for glutamine and Cognitive Decline
| Article | Year |
|---|---|
Comparative plasma metabolomic analysis to identify biomarkers for lead-induced cognitive impairment.
Topics: Arachidonic Acid; Biomarkers; Cognitive Dysfunction; Docosahexaenoic Acids; Glutamine; Humans; Lead; Metals, Heavy | 2022 |
Neurometabolic correlates of posturography in normal aging and older adults with mild cognitive impairment: Evidence from a
Topics: Aged; Aging; Aspartic Acid; Choline; Cognitive Dysfunction; Creatine; Glutamine; Humans; Inositol; Proton Magnetic Resonance Spectroscopy; Receptors, Antigen, T-Cell | 2023 |
Glutamine Supplementation Preserves Glutamatergic Neuronal Activity in the Infralimbic Cortex, Which Delays the Onset of Mild Cognitive Impairment in 3×Tg-AD Female Mice.
Topics: Alzheimer Disease; Animals; Cognitive Dysfunction; Dietary Supplements; Disease Models, Animal; Female; Glutamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; tau Proteins | 2023 |
Neonatal Maternal Separation Induces Sexual Dimorphism in Brain Development: The Influence on Amino Acid Levels and Cognitive Disorders.
Topics: Amino Acids; Animals; Brain; Cognitive Dysfunction; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Glycine; Hippocampus; Male; Maternal Deprivation; Memory Disorders; Rats; Receptor, Metabotropic Glutamate 5; Sex Characteristics | 2023 |
Glutamine antagonism attenuates physical and cognitive deficits in a model of MS.
Topics: Animals; Azo Compounds; Behavior, Animal; Caproates; Cells, Cultured; Cognitive Dysfunction; Encephalomyelitis, Autoimmune, Experimental; Female; Glutamine; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis | 2019 |
High-resolution metabolomic profiling of Alzheimer's disease in plasma.
Topics: Aged; Aged, 80 and over; Alkaloids; Alzheimer Disease; Benzodioxoles; Biomarkers; Chromatography, Liquid; Cognitive Dysfunction; Female; Glutamine; Humans; Male; Mass Spectrometry; Metabolome; Metabolomics; Middle Aged; Piperidines; Polyunsaturated Alkamides | 2020 |
Circulating Glutamine and Alzheimer's Disease: A Mendelian Randomization Study.
Topics: Aged; Alzheimer Disease; Blood-Brain Barrier; Brain; Cognition; Cognitive Dysfunction; Female; Genome-Wide Association Study; Glutamine; Humans; Male; Mendelian Randomization Analysis; Neuroprotective Agents; Receptors, Glutamate | 2020 |
Glutamine Supplementation Prevents Chronic Stress-Induced Mild Cognitive Impairment.
Topics: Animals; Behavior, Animal; Cognitive Dysfunction; Disease Models, Animal; Glutamine; Hippocampus; Male; Maze Learning; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Stress, Psychological | 2020 |
Neural Signatures of Memory Encoding in Schizophrenia Are Modulated by Antipsychotic Treatment.
Topics: Adult; Antipsychotic Agents; Cognitive Dysfunction; Default Mode Network; Female; Glutamic Acid; Glutamine; Hippocampus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Memory; Memory, Episodic; Mental Recall; Proton Magnetic Resonance Spectroscopy; Recognition, Psychology; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2021 |
Comprehensive metabolomics profiling reveals common metabolic alterations underlying the four major non-communicable diseases in treated HIV infection.
Topics: Adolescent; Adult; Aged; Alanine; Aspartic Acid; Atherosclerosis; Cognitive Dysfunction; Female; Glutamic Acid; Glutamine; Glycerophospholipids; HIV Infections; Humans; Liver Cirrhosis; Male; Metabolome; Middle Aged; Plasmalogens; Renal Insufficiency | 2021 |
(S)-Oxiracetam is the Active Ingredient in Oxiracetam that Alleviates the Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Astrocytes; Cerebral Cortex; Cerebrovascular Circulation; Cognitive Dysfunction; Dementia, Vascular; Disease Models, Animal; Glutamic Acid; Glutamine; Male; Neurons; Neuroprotective Agents; Nootropic Agents; Pyrrolidines; Rats; Rats, Wistar; Spatial Learning; Spatial Memory; Stereoisomerism; White Matter | 2017 |
Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arachidonic Acid; Biomarkers; Chromatography, Liquid; Cognitive Dysfunction; Cytidine; Gas Chromatography-Mass Spectrometry; Glutamic Acid; Glutamine; Humans; Male; Mass Spectrometry; Metabolomics; Middle Aged; Reproducibility of Results; Sarcosine; Sensitivity and Specificity; Thymine | 2014 |
Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
Topics: Adult; Aged; Alzheimer Disease; Brain; Brain Mapping; Cognitive Dysfunction; Cohort Studies; Face; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mental Status Schedule; Names; Neuropsychological Tests; Pattern Recognition, Physiological; ROC Curve | 2016 |
Creatine, Glutamine plus Glutamate, and Macromolecules Are Decreased in the Central White Matter of Premature Neonates around Term.
Topics: Cognitive Dysfunction; Creatine; Diffusion Magnetic Resonance Imaging; Female; Glutamic Acid; Glutamine; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Occipital Lobe; Proton Magnetic Resonance Spectroscopy; Retrospective Studies; Taurine; Temporal Lobe; Term Birth; Thalamus; White Matter | 2016 |
Glutamate-glutamine and GABA in brain of normal aged and patients with cognitive impairment.
Topics: Adult; Aged; Aging; Alzheimer Disease; Analysis of Variance; Case-Control Studies; Cognitive Dysfunction; Early Diagnosis; Female; gamma-Aminobutyric Acid; Glutamates; Glutamine; Gyrus Cinguli; Hippocampus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Young Adult | 2017 |
N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
Topics: Aged; Alzheimer Disease; Aspartic Acid; Choline; Cognitive Dysfunction; Disease Progression; Female; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Temporal Lobe | 2011 |